Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study | Hypertension Research
PDF] Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT): Rationale and Study Design | Semantic Scholar
Azilsartan Medoxomil Clinical Trials Available in Full Publication | Download Table
ARB Approximate Dose Equivalence for BP Lowering and ... | GrepMed
Cancers | Free Full-Text | Angiotensin Inhibition, TGF-β and EMT in Cancer | HTML
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events | NEJM
Azilsartan: Current Evidence and Perspectives in Management of Hypertension
Lisinopril vs. Losartan: How Do They Compare? - Health Guide
Clinical Efficacy of EDARBI (azilsartan medoxomil)